Sign in

Christina Kajba

@ckajba.bsky.social
44 followers 77 following 2 posts

Doctoral Clinical Fellow in the Genome Function Laboratory @TheCrick

PostsRepliesMedia
Christina Kajba @ckajba.bsky.social · 13/06/2026
Excited to be back at #eshg2026. If you're interested in high-throughput prime editing of non-coding variants, come see my talk! Tomorrow at 11.15 in session C16.
020
Reposted by Christina Kajba
Nicky Whiffin @nickywhiffin.bsky.social · 09/04/2026
Super excited that our two companion papers on saturation genome editing (SGE) of RNU4-2 and discovery of a novel recessive neurodevelopmental disorder (NDD) were published yesterday 🥳 SGE experiment: www.nature.com/articles/s41... Recessive NDD characterisation: www.nature.com/articles/s41... 🧵
nature.com
Saturation editing of RNU4-2 reveals distinct dominant and recessive disorders - Nature
Saturation genome editing of RNU4-2 identifies the functional and clinical impact of variants across the entire gene and delineates variants that cause a new recessive neurodevelopmental disorder distinct from ReNU syndrome.
45016
Reposted by Christina Kajba
Greg Findlay @gregfindlay.bsky.social · 24/01/2026
Our latest story is now on bioRxiv. We present PETRA, a new method for deciphering how sequence variants impact gene regulation at scale. www.biorxiv.org/content/10.1... This work was led by Magdalena Armas Reyes, a @crick.ac.uk PhD student until very recently. Congrats, Dr. Armas! 🧵 1/9
biorxiv.org
183
Reposted by Christina Kajba
The Francis Crick Institute @crick.ac.uk · 04/09/2025
Congratulations to @gregfindlay.bsky.social on being awarded a €1.5 million Starting Grant from the @erc.europa.eu to take a closer look at possible disease variants hiding in the dark genome. www.crick.ac.uk/news/2025-09...
crick.ac.uk
€1.5 million to uncover disease risk hiding in non-coding DNA
Greg Findlay, Group Leader of the Genome Function Laboratory at the Francis Crick Institute, has been awarded a Starting Grant from the European Research Council for €1.5 million to take a deep dive i...
2326
Christina Kajba @ckajba.bsky.social · 01/09/2025
Looking forward to the Variant Effects Seminar tomorrow! @michaelherger.bsky.social and I will present our pooled prime editing platform for high-throughput variant screening.
091
Reposted by Christina Kajba
Greg Findlay @gregfindlay.bsky.social · 18/08/2025
Our latest research is out today on ‪@medrxivpreprint.bsky.social: www.medrxiv.org/content/10.1... Saturation genome editing of BRCA1 across cell types accurately resolves cancer risk. Led by the amazing Phoebe Dace. This one’s packed full of data, so check out the paper. Quick highlights… 🧵 1/n
medrxiv.org
Saturation genome editing of BRCA1 across cell types accurately resolves cancer risk
Germline pathogenic BRCA1 variants predispose women to breast and ovarian cancer. Despite accumulation of functional evidence for variants in BRCA1 , over half of reported single-nucleotide variants (...
16921
Reposted by Christina Kajba
Greg Findlay @gregfindlay.bsky.social · 16/06/2025
Check out @ckajba.bsky.social and Michael Herger's concise description of their recent work. Thanks to Nature Reviews Genetics for featuring this. rdcu.be/eraxZ
rdcu.be
Determining variant effects with pooled prime editing
Nature Reviews Genetics - In this Tools of the Trade article, Christina Kajba and Michael Herger describe their screening platform, based on pooled prime editing, for large-scale functional...
0185